Home
This site is intended for healthcare professionals
Advertisement

Primary Care Updates 2024: Palliative Emergencies from Primary Care perspective

Share
Advertisement
Advertisement
 
 
 

Summary

This on-demand teaching session focuses on Palliative Care Emergencies for medical professionals. It covers identifying and treating spinal cord compression, superior vena cava obstruction, and major haemorrhage - common emergencies encountered in palliative care. The instructors will explain cancer patient incidence rates, causes, symptoms, diagnostic procedures, treatments and the importance of early detection. Attendees will also learn how to manage patients from a holistic perspective, including pain and bowel management, providing psychological support, rehabilitation, and when to consider home, nursing home, or hospice care options. Understand the place of care and patient survival rates. Further, focused discussion will also cover the roles of social workers and physiotherapists in the care of these patients. Important for professionals seeking to improve patient prognosis and quality of life.

Generated by MedBot

Description

About the MedAll Primary Care CPD Programme

We are passionate about making medical education free and more accessible. In light of the increasing financial pressures faced by healthcare professionals, including the rising cost of living and strained practice finances, we felt compelled to do something. It's why we have introduced a no-cost CPD programme for doctors, nurses and other healthcare professionals working in primary care. We recognise that the high expense of traditional CPD update courses is a significant barrier, and by collaborating as an entire primary care community we hope we can offer a practical, accessible alternative.

About our speaker: Dr Jayne McAuley

Dr. Jayne McAuley, a Consultant in Palliative Medicine with SHSCT, specialises in comprehensive palliative care. With extensive experience in managing complex cases, she is dedicated to improving patient outcomes through evidence-based practices and multidisciplinary collaboration. Dr. McAuley is a respected educator and advocate for palliative care advancements.

Who Should Join?

✅ GPs

✅ Primary care and practice nurses

✅ Practice pharmacists

✅ Other allied healthcare professionals in primary care

Note: this event is not formally accredited by an external organisation for CPD points. The current guidance for GP CPD is that it is appropriate that the credits you self-allocate should equal however many hours you spent on learning activities, as long as they are demonstrated by a reflective note on lessons learned and any changes made or planned (if applicable).

Learning objectives

  1. Identify and understand the common emergencies that occur in Palliative Care including complications like spinal cord compression, major haemorrhage, malignant hypercalcaemia, and SVC obstruction.
  2. Recognise the symptoms and signs of spinal cord compression, comprehend its incidence in cancer patients and understand the importance of early diagnosis and the measures required for management.
  3. Learn about the guidelines for treating and managing spinal cord compression emergencies according to NICE guidelines, including pain assessment, medication, and imaging techniques.
  4. Understand the complex issues presented by Superior Vena Cava (SVC) obstruction, including understanding its aetiology, clinical features, investigation, and management.
  5. Gain knowledge on the management of major haemorrhage in advanced cancer patients, recognising the causes, the measures for symptom management and support, and the importance of immediate response.
Generated by MedBot

Related content

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Palliative Care Emergencies Consultant Palliative MedicineEmergencies in Palliative Care ● What are they? ● How do we recognise them? ● What action is needed?Which emergencies occur in Palliative Care? ● Spinal cord compression ● SVC obstruction ● Major haemorrhage ● Malignant hypercalcaemiaSpinal Cord CompressionSpinal Cord Compression Incidence: • All cancer patients 5% • Patients with vertebral metastases 10% Most common malignant causes: - Breast ca - Renal ca - Prostate ca - Myeloma - Lung ca - LymphomaPathophysiology ● Spinal cord oedema ● Ischaemia ● Direct pressureSites ● Thoracic 70% ● Lumbar 20% ● Cervical 10% ● Multiple 20% Early diagnosis crucial to prognosis ● Some patients experience significant delays from the time when they first develop symptoms to referral ● Nearly half of all patients with MSCC are unable to walk at the time of diagnosis ● Early detection, treatment and care can reduce the risk of developing avoidable disability and premature death HIGH INDEX SUSPICION (CLINICIANS/PATIENTS)NICE Guideline, 2023Symptoms or signs of SCC (Box 1) ● Bladder or bowel dysfunction ● Gait disturbance or difficulty walking ● Limb weakness ● Neurological signs of spinal cord or cauda equnia compression ● Numbness, paraesthesia or sensory loss ● Radicular painClinical Features Lesions above L1 Lesions below L1 (Upper motor neurone signs) (Cauda equina syndrome/Lower motor signs) ● Back pain (90%) – Increased on coughing ● Sciatic pain – Localised/radicular ● Saddle anaesthesia ● Muscle weakness ● Reduced tone (check ● Sensory loss anus) ● Increased tone ● Plantars absent/ ● Abnormal reflexes (upper downgoing motor pattern) ● Urinary retention ● Sphincter dysfunction (late)NICE Guidance ● Treat as an emergency and contact MSCC coordinator when available (currently oncology registrar on call) ● Start immobilisation if syms/signs of spinal instability ● Start Dexamethasone 16mg daily ● Assess pain and ensure analgesics prescribed ● Carry out MRI within 24 hours (or CT if MRI contraindicated)Spinal Stability ● Consider specialised CT imaging to assess spinal stability if surgery planned ● Consider use of validated scoring system for spinal stability as part of the full holistic clinical assessment ● Immobilise patients with suspected/confirmed SCC + neurological syms or signs suggesting spinal instability and seek specialist advice ● Consider immobilising patients with suspected/confirmed SCC + moderate to severe pain on movement and seek specialist adviceManagement ● XRT – - aim deliver within 24 hrs unless lost all power >2 wks and pain free or prognosis very poor ● Surgical decompression (may offer better outcome if pt suitable) ▪ - If diagnosis required – - Prognosis longer 3 months – - Not tetraplegic/paraplegia more than 24 hours – - Fit and willing for surgery ● External spinal support if symptoms of spinal instability (eg: halo vest)Symptom Management ● Pain management – (including Bisphsphonates (breast cancer & myeloma) & Denosumab (solid tumors with bone mets but not prostate cancer)) ● Bowel management ● Depends on level of involvement ● Above L1 local reflex preserved so keeping stool soft/firm plus regular PR ● intervention Below L1 may have atonic bowel with loss of local reflex. Manual evacuation may be necessary ● Maintaining dignity of patient is a priority ● Psychological Support Rehabilitation ● Physiotherapy/Occupational therapy –Key role to maximise potential in function and independence ● Social worker –Increase care package incl. respite –Psychological support pt/familyWhy important for Physio / OT? ● Referrals received for: – Stair assessments – Mobility assessments – Transfers – Pain / weakness / sensory problems – Continence issues – Pressure care problems – Might be first professional involved Why is this important for SW? ● Prevention! Report new symptoms/concerns to MDT ● Resource implications - New care package for new physical needs - Significant increase to existing care package - Permanent placement if unable to stay at home - Liaison with/referral to other professionals, services ● Other SW intervention Support with major changes/losses: - client and family - practical, financial, preparation, emotional, family issues etc - negotiating systems, advocacy etc - pre-bereavement/bereavement support/resourcesOutcome – Less than 50% are able to walk at time of diagnosis ● 67% of these pts will see no functional improvement even with treatment – 81% of those walking at time of diagnosis are walking at 1 month with a significantly better overall survival – Loss of sphincter control is a bad prognostic indicator Early detection=better outcomePlace of care • - Home if function allows – - Nursing home esp if paraplegic – - Hospice if specialist physical/psychological needs – - Major life change with poor prognosis so needs good liason with inpt/comm. servicesSurvival ● Median survival is 7-10 months ● Less than 30% survival at 1 yearWhat does that mean for me? High index of suspicion Clinically assess syms/signs esp neurological signs and spinal stability If positive findings: Start steroids Treat pain Arranging urgent admission through Emergency Department for investigation (may need to consider spinal precautions depending on clinical findings)Superior Vena Cava ObstructionSuperior vena caval obstruction ● 50% first presentation ● Aetiology –Ca bronchus 70% –Lymphoma 8% –Other ca 10% – Benign 12% (goitre, AA) ● Need accurate histological diagnosis prior to treatmentClinical features Symptoms ● Signs SOB (tracheal oedema) ● Tachypnoea ● Headache (cerebral ● Periorbital/hand/arm oedema) oedema ● Visual changes ● ● Dilated collateral sup. Dizziness./syncope chest veins ● Facial/periorbital ● Cyanosis puffiness ● Neck/arm/hand ● Non-pulsatile distension of neck swelling veinsInvestigations ● CXR ● CT SCAN ● Specialist referral if tissue diagnosis requiredManagement ● Symptomatic management and support ●Upright position ● Oxygen ●Analgesia ●Anxiolytics ● Corticosteroids: Dexamethasone 16mg ● Oncology opinion ?radiotherapy/chemotherapy ● Balloon venoplasty and SVC stenting provides rapid relief of symptomsWhat does that mean for me? ● Clinically assess syms/signs ● If positive findings: ● Start steroids ● Treat symptoms ● Arranging urgent admission through Emergency Department for investigationPalliative Management of Major Haemorrhage in advanced cancerCauses – Erosion main vessel (carotid artery) – Direct from tumour (lung/gastric/sarcoma) – Bleeding tendency ●Low plt ●DIC ●Uraemia ●AnticoagulantsManagement of non-major haemorrhage May be treated by oncological, systemic, and local measures ● Palliative radiotherapy ● Oral tranexamic acid 1g tds ● Other measures: ● Sucralfate ● 1:1000 adrenaline soaks ● dressings KEEP CALM and ACTIVATE THE MAJOR HAEMORRHAGE PROTOCOLWhat does that mean for me? ● Palliative Management plan appropriate when lead clinician and MPT clear that resuscitation and acute, active management not appropriate. ● Takes into account – Stage of illness – Treatment options available – Patient choicePreparation for Major Haemorrhage ● Sensitive communication with patient and family ● Liason with OOH services/NIAS ● Equipment (gloves/PPE/waste bags/dark towels) ● Medication –Buccal/IM Midazolam –AnalgesiaAwareness/Preparation “A” ● Engage in sensitive discussion with pt/family and agree plan of care (ACP) ● Document and communicate individualised management plan to all relevant care providers (primary care team/ NIAS/OOH) ● Prescribe Midazolam crisis dose and inform pt/family and relevant healthcare providers ● Prepare pts environment (dark towels/PPE/ clinical waste bags)Be the“ B” DO NOT LEAVE THE PATIENT ALONECalm/Comfort “C” ● Call for help ● Use dark dressings or towels ● Position patient as appropriate and use suction if available/ appropriate ● If trained HCP present can administer IM Midazolam 10mg every 15 mins as required (maximum 30mg) ● Buccal Midazolam may be an alternative if family comfortable/ trained and if appropriate (Buccal Midazolam 5-10mg every 15 mins if required with maximum 30mg) ● Use clinical waste bags for used towels/dressingsAfter a Major Hae“D”rhage Debriefing: ● Disposal of waste ● Immediate support for family ● Immediate support for professionals ● Psychological support/bereavement counsellingMalignant Hypercalcaemia Commonly associated with: • Squamous carcinoma (bronchus, ENT , etc) • Breast, prostate, renal tract malignancies • Multiple myeloma • LymphomaManagement ● Fluid replacement ● Bisphosphonates (caution with renal failure) C.Ca 2+ levels decline after 48hrs and continue to fall for ~ 7 days ● Resistance can be treated with repeat dose of bisphosphonate or Denosumab (seek advice on dose/ interval) 80% OF PATIENTS WITH MALIGNANT HYPERCALCAEMIA DIE WITHIN ONE YEAR What does that mean for me? ● High index of suspicion if patient confused or nauseated. ● Check U&E and Corrected Calcium ● Will usually need IV fluids and IV bisphosphonate (red list) so usually inpatient treatment but sometimes managed at homeANY QUESTIONS?